# FlowCLOc, a New Tool for Selecting the Most Appropriate Antibodies in Flow Cytometry

**Authors:** Valentina Serra, Valeria Orrù, Sandra Lai, Mariano Dei, Michele Marongiu, Maria Grazia Piras, Francesca Virdis, Matteo Floris, Giuseppe Delogu, Valeria Lodde, Mauro Pala, Maristella Pitzalis, Edoardo Fiorillo, Francesco Cucca

PMC · DOI: 10.3390/ijms27041664 · 2026-02-09

## TL;DR

The paper introduces FlowCLOc, a tool that helps scientists choose the best antibodies for flow cytometry when working with frozen or fresh immune cell samples.

## Contribution

FlowCLOc is a novel public catalogue that provides marker expression variability data to streamline antibody selection for flow cytometry.

## Key findings

- Cryopreservation altered the expression of over 20% of 283 markers in lympho-monocytes and 262 in blood.
- FlowCLOc enables efficient panel design by cataloging marker variability between fresh and frozen samples.
- The tool reduces the need for time-consuming preliminary tests in flow cytometry experiments.

## Abstract

Circulating immune cells are frequently phenotyped by flow cytometry starting from frozen samples. However, cryopreservation can affect marker expression and cell recovery. To understand which antigens are detectable and reliable after sample cryopreservation, we compared 438 antibodies measured on B, T, and NK-enriched cells and monocytes in frozen lympho-monocytes and blood with the corresponding fresh blood samples. Cryopreservation affected the expression of 283 markers in lympho-monocytes and 262 in blood, modifying them by more than 20% with respect to fresh blood. Thus, it is essential to carefully evaluate antibody performance when working with frozen samples. To maximize the usability of our results, make them publicly accessible and ready to visualize, we created a catalogue of marker expression variability before and after freezing, namely FlowCLOc. This catalogue simplifies flow cytometry panel design, reducing time-consuming preliminary tests to select the most appropriate and specific markers for staining both frozen and fresh samples.

## Full-text entities

- **Genes:** CD58 (CD58 molecule) [NCBI Gene 965] {aka LFA-3, LFA3, ag3}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, CR2 (complement C3d receptor 2) [NCBI Gene 1380] {aka C3DR, CD21, CR, CVID7, SLEB9}, CXCR1 (C-X-C motif chemokine receptor 1) [NCBI Gene 3577] {aka C-C, C-C-CKR-1, CD128, CD181, CDw128a, CKR-1}, CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, FCGR2A (Fc gamma receptor IIa) [NCBI Gene 2212] {aka CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1}, CCR6 (C-C motif chemokine receptor 6) [NCBI Gene 1235] {aka BN-1, C-C CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3}, FUT4 (fucosyltransferase 4) [NCBI Gene 2526] {aka CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX}, CD33 (CD33 molecule) [NCBI Gene 945] {aka CD33rSiglec, SIGLEC-3, SIGLEC3, p67}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}, CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, CD27 (CD27 molecule) [NCBI Gene 939] {aka S152, S152. LPFS2, T14, TNFRSF7, Tp55}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, CD19 (CD19 molecule) [NCBI Gene 607898], CD14 (CD14 molecule) [NCBI Gene 929], CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, F11R (F11 receptor) [NCBI Gene 50848] {aka CD321, JAM, JAM1, JAMA, JCAM, KAT}, CD24 (CD24 molecule) [NCBI Gene 100133941] {aka CD24A}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, CCR2 (C-C motif chemokine receptor 2) [NCBI Gene 729230] {aka CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2}
- **Diseases:** tumor (MESH:D009369), inflammatory (MESH:D007249), injury to (MESH:D014947)
- **Chemicals:** Cy5 (MESH:C085321), DMSO (MESH:D004121), glucose (MESH:D005947), sodium heparin (MESH:D006493), Glutamine (MESH:D005973), BD Pharm (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** HB7 — Mus musculus (Mouse), Hybridoma (CVCL_D038), SK1 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_0068), LS1321D9 — Homo sapiens (Human), Astrocytoma, Cancer cell line (CVCL_0110), HIT2 — Mesocricetus auratus (Golden hamster), Transformed cell line (CVCL_0301), L128 — Homo sapiens (Human), Mantle cell lymphoma, Cancer cell line (CVCL_C5U3)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940311/full.md

---
Source: https://tomesphere.com/paper/PMC12940311